Skip to content

Clinical trials

Prostatic Neoplasms trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Neoplasms Country / region: Australia Clear all

216 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20022
20034
20042
20054
20064
20073
20087
20097
20104
20116
20125
20138
20148
20157
20167
20179
20185
20199
202016
202111
202216
202314
202417
202521
202614

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed85
Recruiting53
Active, not recruiting49
Terminated19
Unknown status6
Not yet recruiting2
Approved for marketing1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca20
Pfizer11
Novartis Pharmaceuticals9
Amgen8
Peter MacCallum Cancer Centre, Australia8
Bristol-Myers Squibb7
Janssen Research & Development, LLC7
Royal North Shore Hospital7
Sanofi6
Eli Lilly and Company5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Neoplasms216
Breast Neoplasms30
Ovarian Neoplasms21
Pancreatic Neoplasms19
Neoplasms18
Neoplasm Metastasis16
Colorectal Neoplasms12
Melanoma12
Carcinoma, Non-Small-Cell Lung11
Urinary Bladder Neoplasms11

Trials

Showing 26 to 50 of 216. Each trial links to its page on Pharma Observatory.

116 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.